Home
/
Renalytix plc
/
Financials
/
Quarterly
Renalytix plc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Renalytix plc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Sep 30, 2024
$522.0K
Nov 19, 2024
Q3
2024
Mar 31, 2024
$535.0K
May 15, 2024
Q2
2024
Dec 31, 2023
$709.0K
Feb 14, 2024
Q1
2025
Sep 30, 2023
$459.0K
Nov 19, 2024
Q3
2024
Mar 31, 2023
$724.0K
May 15, 2024
Q2
2024
Dec 31, 2022
$1.19M
Feb 14, 2024
Q1
2024
Sep 30, 2022
$969.0K
Nov 14, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Sep 30, 2024
($4.73M)
Nov 19, 2024
Q3
2024
Mar 31, 2024
($7.74M)
May 15, 2024
Q3
2024
Dec 31, 2023
($8.49M)
May 15, 2024
Q2
2024
Dec 31, 2023
($8.49M)
Feb 14, 2024
Q3
2024
Sep 30, 2023
($10.15M)
May 15, 2024
Q2
2024
Sep 30, 2023
($10.15M)
Feb 14, 2024
Q1
2025
Sep 30, 2023
($10.15M)
Nov 19, 2024
Q3
2024
Mar 31, 2023
($12.11M)
May 15, 2024
Q3
2024
Dec 31, 2022
($10.44M)
May 15, 2024
Q2
2024
Dec 31, 2022
($10.44M)
Feb 14, 2024
Q2
2024
Sep 30, 2022
($11.95M)
Feb 14, 2024
Q3
2024
Sep 30, 2022
($11.95M)
May 15, 2024
Q1
2024
Sep 30, 2022
($11.95M)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Sep 30, 2024
($4.09M)
Nov 19, 2024
Q3
2024
Mar 31, 2024
($6.55M)
May 15, 2024
Q2
2024
Dec 31, 2023
($8.64M)
Feb 14, 2024
Q1
2025
Sep 30, 2023
($8.89M)
Nov 19, 2024
Q3
2024
Mar 31, 2023
($10.92M)
May 15, 2024
Q2
2024
Dec 31, 2022
($9.65M)
Feb 14, 2024
Q1
2024
Sep 30, 2022
($11.72M)
Nov 14, 2023